LENSAR, Inc.

NASDAQ:LNSR

Medical - Devices

Healthcare
$4.85 -8.15%

-$0.51 today

Market cap
$59.63M
Beta
0.87
P/E (TTM)
2.4
EPS (TTM)
$2.42
52W Low $5.06High $13.47

Volume 0.06M

Average 0.09M

LNSR Total Current Assets

All assets expected to be converted to cash or used up within one year.

LENSAR, Inc.NASDAQ: LNSR

Total Current Assets · Q1 FY2026 · quarter ended Mar 2026

Total current assets falls 13.8% from a year ago

Total current assets stood at $42.4M at the end of Q1 FY2026, down 13.8% from a year earlier and down 9.3% from the prior quarter. Over 3 fiscal years it compounded at +11.5% a year.

Context

  • Total current assets amounted to 64.0% of total assets at the end of Q1 FY2026, down 3.4 pp from a year earlier.
  • Total current assets increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total current assets keeps falling in the next quarterly balance sheet after a -13.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$42.4M-9.3% QoQ
Last fiscal yearDec 2025
$46.77M+11.4% YoY
Year agoMar 2025
$49.19M-13.8% since
Total Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-13.8%——
1 year+11.4%——
3-year CAGR+11.5%——
5-year CAGR——
10-year CAGR——

Total Current Assets history

USD · from the balance sheet

Latest · FY2025
46.77M USD
Year-over-year change
+11.4%
4-year CAGR
+1.1%

Total Current Assets vs competitors

How LNSR compares with its peers on the latest reported figures

  • LNSR's Mar 2026 total current assets of $42.4M is the lowest of the 10 companies compared; the peer median is $82.45M.
  • Its year-over-year change of -13.8% is the 7th highest of 10, against a peer median of +4.5%.
  • Total current assets amounts to 64.0% of total assets for LNSR, versus a peer median of 95.0%.
LNSR Competitors Peer median
Total Current Assets for LNSR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AVRAnteris Technologies Global Corp.Mar 2026$286.67M +441.1%+8.6%97.3%
CRBPCorbus Pharmaceuticals Holdings, Inc.Mar 2026$143.57M +4.5%+40.5%99.4%
MXCTMaxCyte, Inc.Mar 2026$122.94M -21.1%-22.3%63.2%
ANIKAnika Therapeutics, Inc.Mar 2026$93.56M -8.7%-15.2%52.2%
OWLTOwlet, Inc.Mar 2026$82.45M +70.3%+16.9%95.0%
PROFProfound Medical Corp.Mar 2026$69.76M +16.4%+18.9%94.7%
TLSITriSalus Life Sciences, Inc.Mar 2026$68.14M +171.5%+23.3%96.0%
RPIDRapid Micro Biosystems, Inc.Mar 2026$49.23M -28.8%-23.9%78.9%
CRDFCardiff Oncology, Inc.Mar 2026$47.34M -42.8%-18.6%96.3%
LNSRLENSAR, Inc.Mar 2026$42.4M -13.8%+11.5%64.0%
Peer median (excluding LNSR) $82.45M+4.5%+8.6%95.0%

Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents31.64M14.67M20.62M16.26M12.97M
Short-term Investments003.44M6.19M5M
Net Receivables4.99M6.24M4.32M6.48M6.38M
Inventory6.49M11.74M15.69M11.43M21.52M
Other Current Assets01.06M2.37M1.62M896K
Total Current Assets44.81M33.72M46.44M41.98M46.77M
Property, Plant & Equipment (Net)7.45M6.88M10.28M664K505K
Goodwill00000
Intangible Assets10.87M12.12M11.03M6.11M5.19M
Long-term Investments0442K492K1.16M0
Tax Assets0(442K)000
Other Non-current Assets3.34M3.13M1.35M16.38M18.96M
Total Non-current Assets21.65M22.13M23.14M24.32M24.66M
Total Assets66.47M55.84M69.59M66.3M71.43M
Account Payables2.69M5.42M4.01M6M18.98M
Short-term Debt00000
Tax Payables00000
Deferred Revenue904K768K1.35M1.68M3.07M
Other Current Liabilities3.38M3.52M4.01M5M15.05M
Total Current Liabilities8.71M11.42M11.63M15M40.57M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities69K167K9.03M30.56M54.89M
Total Non-current Liabilities2.87M2.44M10.78M32.65M56.88M
Total Liabilities11.59M13.86M22.41M47.65M97.45M
Common Stock110K111K113K116K120K
Retained Earnings(77.59M)(97.51M)(111.89M)(143.3M)(177.58M)
Accumulated OCI004K6K4K
Other Stockholders Equity00000
Minority Interest00000
Total Equity54.88M41.98M47.18M18.65M(26.02M)
Total Debt3.32M2.8M2.31M2.61M2.74M
Net Debt(28.32M)(11.87M)(18.31M)(13.65M)(10.24M)

LENSAR, Inc.

NASDAQ:LNSR

Intrinsic Alpha fair value

Locked

Current Price

$4.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.